{"id":"https://openalex.org/W2241107787","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7056","title":"Combination chemotherapy with sunitinib (IND 74019; NSC 736511) for untreated extensive-stage small cell lung cancer (SCLC): CALGB 30504 phase IB safety results.","display_name":"Combination chemotherapy with sunitinib (IND 74019; NSC 736511) for untreated extensive-stage small cell lung cancer (SCLC): CALGB 30504 phase IB safety results.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W2241107787","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7056","mag":"2241107787"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.7056","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7056","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.7056","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079438136","display_name":"Neal Ready","orcid":"https://orcid.org/0000-0003-4414-9432","observed_orcids":["https://orcid.org/0000-0003-4414-9432"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Ready","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006731860","display_name":"Frank Dunphy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Dunphy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084337375","display_name":"Herbert Pang","orcid":"https://orcid.org/0000-0002-7896-6716","observed_orcids":["https://orcid.org/0000-0002-7896-6716"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Pang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"R. Heinze","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Heinze","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006930823","display_name":"Jeffrey Crawford","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Crawford","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109997055","display_name":"Everett E. Vokes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. E. Vokes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"7056","last_page":"7056"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.9769999980926514},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.9110000133514404},{"id":"https://openalex.org/keywords/extensive-stage-small-cell-lung-cancer","display_name":"extensive-stage small cell lung cancer","score":0.8270000219345093},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9380000233650208},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":1.0},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.9789999723434448},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9419999718666077},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8809999823570251},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.7699999809265137},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.7020000219345093}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9264111518859863},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7715943455696106},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.7552914619445801},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.6036491394042969},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5948068499565125},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5874115824699402},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.5369232892990112},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.48808515071868896},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.418806254863739},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.347446084022522},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3228590786457062}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.7056","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7056","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.7056","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4247919392","https://openalex.org/W2136290128","https://openalex.org/W2294802652","https://openalex.org/W2122277870","https://openalex.org/W2175363298","https://openalex.org/W2590344183","https://openalex.org/W1963777952","https://openalex.org/W1984082395","https://openalex.org/W2502608061","https://openalex.org/W2046538477"],"abstract_inverted_index":{"7056":[0],"Background:":[1],"CALGB":[2],"conducted":[3],"a":[4,213,262],"phase":[5,264],"IB":[6],"trial":[7,167,257,266],"to":[8,56,87,159,170,177,261,285,292,337],"determine":[9],"the":[10,186,228],"dose":[11,65,97,194,287],"of":[12,61,67,132,209,221,279,300,321],"sunitinib":[13,187,235,246,270,280,324],"that":[14],"can":[15],"be":[16],"safely":[17],"combined":[18],"with":[19,28,218,237,329],"cisplatin":[20,43,288],"and":[21,34,47,128,156,212,245,249,289,296,317,323],"etoposide":[22,48,290],"in":[23,239,267,309],"extensive":[24,35],"SCLC.":[25],"Methods:":[26],"Patients":[27],"PS":[29],"0-1,":[30],"adequate":[31],"organ":[32],"function":[33],"SCLC":[36],"were":[37,78,85,117,147,157],"eligible.":[38],"The":[39,166,256,277],"treatment":[40,143],"plan":[41],"was":[42,94,109,168,242,247],"80":[44],"mg/m2":[45,50],"d1":[46],"100":[49],"d1-3":[51],"every":[52,75],"21":[53,76],"d":[54,190,225],"up":[55],"6":[57,62,199],"cycles.":[58],"Three":[59],"cohorts":[60],"patients":[63,124,141,179,200,205],"at":[64],"levels":[66],"25,":[68],"37.5,":[69],"or":[70],"50":[71],"mg/day":[72,282],"days":[73,77,283],"1-14":[74,191,284],"planned.":[79],"Every":[80],"2":[81,135],"week":[82],"conference":[83],"calls":[84],"held":[86],"assess":[88],"toxicity.":[89],"Toxicity":[90],"during":[91,153],"cycle":[92,134,181,223],"1":[93,103,182,193],"evaluated":[95],"for":[96,145,195,252],"limiting":[98],"toxicity":[99],"(DLT).":[100],"In":[101,113,137],"cohort":[102,114,138,196,202,233],"prophylactic":[104,172],"granulocyte":[105,149,173],"growth":[106,150,174,304,330],"factor":[107,151,175,305,331],"support":[108,152,176],"not":[110,313,326],"allowed.":[111],"Results:":[112],"1,":[115,139],"there":[116],"no":[118],"protocol":[119],"defined":[120],"DLTs.":[121],"However":[122],"most":[123],"had":[125,215],"prolonged":[126,294],"neutropenia":[127,146,211,217,295,316],"required":[129],"delayed":[130],"start":[131],"\u2265":[133],"chemotherapy.":[136],"two":[140,204],"requiring":[142],"delays":[144],"given":[148,306],"cycles":[154],"3-6":[155],"able":[158],"receive":[160],"therapy":[161],"as":[162],"scheduled":[163],"without":[164],"DLT.":[165],"amended":[169,260],"give":[171],"all":[178,253],"from":[180,207],"onward":[183],"while":[184],"repeating":[185],"25":[188,281],"mg":[189],"level":[192],"2.":[197],"Of":[198],"on":[201,232],"2,":[203,234],"died":[206,231],"complications":[208],"febrile":[210,216],"third":[214],"neutrophil":[219],"count":[220],"zero":[222],"3":[224],"10.":[226],"When":[227],"second":[229],"patient":[230],"concurrent":[236],"chemotherapy":[238,272,308,322],"this":[240,310],"setting":[241,311],"deemed":[243],"unsafe,":[244],"immediately":[248],"permanently":[250],"stopped":[251],"remaining":[254],"patients.":[255],"has":[258],"been":[259],"randomized":[263],"II":[265],"which":[268],"maintenance":[269],"after":[271,307],"is":[273,325],"being":[274],"evaluated.":[275],"Conclusions:":[276],"combination":[278,320],"standard":[286],"appeared":[291],"cause":[293],"an":[297],"unacceptable":[298],"rate":[299],"treatment-related":[301],"mortality.":[302],"Granulocyte":[303],"did":[312],"prevent":[314],"severe":[315],"infections.":[318],"This":[319],"recommended,":[327],"even":[328],"support.":[332],"No":[333],"significant":[334],"financial":[335],"relationships":[336],"disclose.":[338]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2016-06-24T00:00:00"}
